Approvals/CIMA-AEMPS/TIOTEPA HIKMA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

TIOTEPA HIKMA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 405edf2145b3840f
Drug Cima Aemps Name: TIOTEPA HIKMA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 90316
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Marketing Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2025-06-10
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 15 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

TIOTEPA

15 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 10, 2025

Approval ID

405edf2145b3840f

Type

Standard